Boxer Capital’s $18 Million Corvus Pharma Bet Signals Confidence in This Biotech’s Next Phase
17/5 22:46
Key PointsBoxer Capital acquired 1,100,000 shares of Corvus Pharmaceuticals in the first quarter; the estimated trade size was $17.55 million....